Table 2 Comparison of the Cleveland Clinic’s Data with Major Series of Patients with Recurrent Disease treated with IORT
Series | # Pts | Local Control | Distant Metastases | Survival |
|---|---|---|---|---|
MayoClinic (8) | 607 | 3-year: 65% | 3-year: 49% | MS: 36 mo |
5-year: 30% | ||||
MGH(9) | 49 | 5-year: 35% | Overall: 67% | 5-year: 27% |
Norway (10) | 59 | 5-year: | Not Reported | 5-year: 30% |
R0: 70% | ||||
R1: 50% | ||||
Netherlands (11) | 147 | 5-year: 54% | Not Reported | MS: 28 mo |
5-year: 32% | ||||
Spain (12) | 27 | 2-year: 26% | 41% | 5-year: 12% |
France (13) | 73 | 3-year: 31% | Not Reported | 3-year: 31% |
Cleveland Clinic | 32 | 3-year: 56% | 3-year: 64% | MS: 32 mo |
5-year: 16% |